|
 |
Gonal-FThis page contains recent news articles, when available, and an overview of Gonal-F but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Gonal-F (when available) Used for the treatment of female infertility, Follitropin beta or follicle stimulating hormone (FSH) stimulates ovarian follicular growth in women who do not have primary ovarian failure. FSH, the active component of Follitropin beta is the primary hormone responsible for follicular recruitment and development. For treatment of female infertility Mechanism Of Action: FSH binds to the follicle stimulating hormone receptor which is a G-coupled transmembrane receptor. Binding of the FSH to its receptor seems to induce phosphorylation and activation of the PI3K (Phosphatidylinositol-3-kinase) and Akt signaling pathway, which is known to regulate many other metabolic and related survival/maturation functions in cells. News Articles on Follitropin alfa/beta Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs - Dec 17, 2009 As Vice President of Marketing, Endocrinology at EMD Serono, she developed, executed, and managed the national marketing strategies for Saizen®, Gonal-f® ... PR Newswire (press release) EMD Serono, Inc. and Nationally Ranked US Hospital Announce Collaboration in ... - Dec 16, 2009 EMD Serono is a leader in reproductive health, with Gonal-f® (follitropin alfa for injection), Luveris® (lutropin alfa for injection) and Ovidrel® Prefilled ... PR Newswire (press release) Merck Serono Initiates KAMPER, the First Pan-European Registry for Patients ... - Dec 10, 2009 ...interferon beta-1a), infertility (Gonal-f(R), follitropin alpha), endocrine and metabolic disorders (Saizen(R) and Serostim(R), somatropin), (Kuvan(R), ... FOXBusiness Protalix 任命Sandra Lauterbach 為銷售與商æ¥äº‹å‹™éƒ¨å‰¯ç¸½è£? - Dec 17, 2009 ...在擔任EMD Serono內分泌å¸è¡ŒéŠ·éƒ¨å‰¯ç¸½è£?時，她開發ã€?執行並管ç?†Saizenã€?Gonal-f å’ŒSerostim 的全國性行銷ç–略。在任è?·æ–¼Serono 之å‰?，Lauterbach 女士在Genzyme 工作了4 ... 財華網 Merck Serono kundigt Grundlagenforschung und klinischer Forschung bei ... - Dec 16, 2009 Interferon beta-1a), Unfruchtbarkeit (Gonal-f(R), Follitropin alfa), endokrinen und metabolischen Erkrankungen (Saizen(R) und Serostim(R), Somatropin; ... news aktuell Schweiz (Pressemitteilung) Merck Serono annonce une collaboration en recherche fondamentale et en ... - Dec 16, 2009 ...de la médecine de la reproduction (Gonal-f(R), follitropine-alfa), des troubles endocriniens (Saizen(R) et Serostim(R), somatotropine ; Kuvan(R), ... Capital.fr Q3/2009: Merck KGaA Revenues Increase by 2.7% to € 1.9 Billion - Oct 26, 2009 Sales of Merck Serono's top three products – the biologic therapies Rebif®, Erbitux® and Gonal-f® – accounted for half of the division's total sales during ... PharmaLive.com (press release) EMD Serono film contest flags infertility - Nov 9, 2009 EMD Serono's fertility products include recombinant versions of three hormones – Gonal-f, Ovidrel and Luveris – along with Cetrotide, which is used to ... Medical Marketing and Media Video: EMD Serono Holds Topping Off Ceremony to Mark Milestone in the ... - Oct 19, 2009 EMD Serono is a leader in reproductive health, with Gonal-f(®) (follitropin alfa for injection), Luveris(®) (lutropin alfa for injection) and Ovidre(®) ... Reuters Caen utilidades de Merck - Oct 26, 2009 ...en el tercer trimestre un 5,8 por ciento hasta 1.313 millones de euros (1.969 millones de dólares) gracias a medicamentos como Rebif, Erbitux y Gonal-f. ... El Financiero (México) KORREKTUR: Merck KGaA bestätigt und präzisiert Jahresprognose (zwei) - Oct 26, 2009 ...dem Krebsmedikament "Erbitux" und dem Hormon zur Therapie von Unfruchtbarkeit "Gonal-f" erzielte der Konzern die Hälfte der Umsatzerlöse im dritten ... Märkische Allgemeine Merck KGaA erfüllt mit 3Q Erwartungen - LC-Erholung hält an - Oct 26, 2009 ..."Erbitux" und dem Hormon zur Therapie von Unfruchtbarkeit "Gonal-f" - erzielte der DAX-Konzern die Hälfte der Umsatzerlöse im dritten Quartal. ... Märkische Allgemeine Q3 2009: Gesamterlöse von Merck steigen um 2,7% auf 1,9 Mrd € - Oct 29, 2009 Im Juli erteilte die japanische Gesundheitsbehörde die Zulassung für die Indikationserweiterung von Gonal-f zur Behandlung unfruchtbarer Frauen mit ... News-Ticker.org (Pressemitteilung) Serono's Gonal-f against male hypogonadism approved in Japan - Jan 24, 2006 ZURICH (AFX) - Serono SA said the Japanese Ministry of Health has approved Gonal-f 75 IU and Gonal-f 150 IU subcutaneous injection in conjunction with ... Forbes Study Shows Patient Preference for Gonal-f(R) RFF Pen to Treat... - Sep 25, 2006 ROCKLAND, Mass., Sept. 25 /PRNewswire-FirstCall/ -- Serono (virt-x: SEO and NYSE: SRA) today announced the results of a Phase IIIb, prospective, ... Free with registration - PR Newswire - AccessMyLibrary.com Westchester Druggist Held in $4 Million Fraud - Aug 4, 2005 At least three customers were also cheated of their supplies of a drug called Gonal F, used to treat infertility, Ms. Pirro said. The drug induces ovulation ... New York Times Press Release: Study Shows Patient Preference for Gonal-f(R) RFF Pen ... - Sep 25, 2006 Study Shows Patient Preference for Gonal-f(R) RFF Pen to Treat Infertility. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … Release: Merck Serono Submits Application for GONAL-f(R) in Japan... - Oct 24, 2008 Merck Serono Submits Application for GONAL-f(R) in Japan for Ovulation Induction in Infertile Women. from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Serono's Gonal-f(R) Approved in Japan for the Treatment... - Jan 24, 2006 Serono's Gonal-f(R) Approved in Japan for the Treatment of Male Hypogonadotropic Hypogonadism. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Japan pharma: Merck files for wider use of Gonal-f - Oct 27, 2008 German pharmaceutical and chemicals company Merck KGaA (MRK.XE) said Friday that it and its division Merck Serono announced have submitted a supplemental ... $34.00 - EIU Country Analysis - Alacra Store Serono's Gonal-f approved in Japan.(Japan's Ministry of Health and … - Jan 30, 2006 Swiss biotechnology group Serono says that the Japanese Ministry of Health, Labor and Welfare has approved its Gonal-f 75 IU and Gonal-f 150 IU (follitropin ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Rebif®, Gonal-f®, Luveris®, Ovidrel®/Ovitrelle®, Serostim®, Saizen®, ... - Jul 3, 2005 Serono is a biotechnology company headquartered in Geneva, Switzerland. The company was founded in 1906 in Italy. A key step in its development was the ... chemie.de SERONO'S GONAL-F APPROVED IN JAPAN FOR HYPOGONADISM. - Mar 1, 2006 Serono (virt-x: SEO and NYSE: SRA) has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Gonal-f(R) 75 IU and ... $4.95 - Worldwide Biotech - ECNext In vitro field facing slowdown. - Nov 14, 2005 For more than two decades, the field expanded explosively, revolutionizing a whole generation's concept of babymaking and producing more than 1 million ... Free with registration - Boston Globe - AccessMyLibrary.com How to Deal with the High Cost of Fertility Meds - Nov 24, 2008 ...by Neighborhood Editor. When couples decide they want a baby they want a baby now, or at least nine months from now. So when month after month of "TTC" ... Fertility Neighborhood Merck Serono picks Huntsworth for infertility work - Jan 26, 2007 Newly merged biopharmaceutical company Merck Serono has awarded Huntsworth Health the UK account for one of biggest selling drugs. ... Pharmafocus Personalized Approach To Ovarian Stimulation Achieves High ART … - Jul 8, 2007 An international group of fertility specialists has developed an easy-to use mathematical formula that allows a personalised approach to ovarian stimulation ... Medical News Today - Medical News Today (press release) High costs drive black market in fertility drugs - Oct 13, 2008 Three 900 IU Gonal F for sale ... I need some money to pay for my new meds. $250 per pen. My doctor says I'm too young for Clomid, but I have had enough of ... $2.95 - The Sun - NewsBank Follitropin Alfa (Systemic).(Gonal-F drug overview)(Drug overview) - Aug 1, 2006 Follitropin alfa (fol-li-TROE-pin AL-fa) is a hormone identical to follicle-stimulating hormone (FSH) produced by the pituitary gland. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Q1 2005 Serono SA Earnings Conference Call - Final. - Apr 22, 2005 OPERATOR: Good afternoon. This is the conference call operator. Welcome and thank you for joining the Serono first quarter 2005 results conference call. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Serono Q2 net profit rises 8 pct, sales disappoint - UPDATE - Jul 27, 2006 GENEVA (AFX) - Swiss pharmaceutical company Serono SA reported second quarter net profit of 189.2 mln usd, up from 175.1 mln a year ago, citing an improved ... Forbes Q4 2004 Serono SA Earnings Conference Call - Final. - Feb 2, 2005 OPERATOR: Good morning. This is the Chorus Call conference operator. Welcome and thank you for Serono's full year 2004 results conference call. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Personalized approach to ovarian stimulation achieves high ART … - Jul 2, 2007 Lyon, France -- An international group of fertility specialists has developed an easy-to use mathematical formula that allows a personalised approach to ... eurekalert.org Personalized Approach To Ovarian Stimulation Achieves High ART … - Jul 5, 2007 ScienceDaily (July 5, 2007) — An international group of fertility specialists has developed an easy-to use mathematical formula that allows a personalised ... sciencedaily.com … , More Controlled Stimulation With MENOPUR(R) Than Gonal-f(R) in Ov - Jun 7, 2006 ...of MENOPUR compared to GONAL F on ... rates - 727 patients ( HP-hMG:373, rFSH:354 ... agonist (daily or depot) - HP-hMG (MENOPUR) vs rFSH (GONAL F ... ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Results From IMPROVE Study Show Therapeutic Effect of … - Sep 22, 2008 Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis.(Clinical report) from PR ... Pay-Per-View - PR Newswire Europe - HighBeam Research Menopur efficacy recognises infertility drug limitations - Jun 22, 2005 Ferring Pharmaceuticals has demonstrated in its latest study with Menopur, resulted in five more pregnancies per 100 women treated, compared to current ... DrugResearcher.com Research identifies predictors for successful IVF. - Oct 17, 2005 Ferring Pharmaceuticals presented the results of a landmark clinical trial on 17 Oct 2005 - the largest in vitro fertilization (IVF) trial powered on ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Company Profile Report - Mar 29, 2008 Market Cap. n/a. Current Shares Outstnd. n/a. Contact Name. Contact Phone. City, State, ,. Dividends Per Common Share, n/a. Dividend Yield, n/a ... $50.00 - Revere Reports - Revere Serono Announces Formal Conclusion of Serostim Settlement. - Dec 15, 2005 GENEVA, and ROCKLAND, Mass., Dec. 15 /PRNewswire-FirstCall/ -- Serono (virt-x: SEO; NYSE: SRA) announced today that one of its US affiliates has voluntarily ... Free with registration - PR Newswire - AccessMyLibrary.com Q1 2006 Serono SA Earnings Conference Call - Final. - Apr 20, 2006 OPERATOR: Good morning and good afternoon. This is the Chorus Call conference operator. Welcome and thank you for joining Serono's first quarter 2006 ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Company Profile Report - Mar 1, 2008 Serophene (Clomiphene Citrate); Gonal-F Pen (Follitropin Alfa Injection) ... Gonal-F (Follitropin Alfa). Weight Management. Cachexia. Growth Hormones ... $50.00 - Revere Reports - Revere Article: The filled pen; selected non-fiction.(Brief Article)(Book... - May 1, 2007 The filled pen; selected non-fiction.(Brief Article)(Book Review) ... find Reference & Research Book News articles. 9780802093998 The filled pen; ... Pay-Per-View - Reference & Research Book News - HighBeam Research Serono Announces Significant Advances in Identifying Most Viable … - Oct 17, 2005 ROCKLAND, Mass., Oct. 17 /PRNewswire-FirstCall/ -- Serono (virt-x: SEO and NYSE: SRA) announced today the results of two research studies investigating ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Unique Three-Year Data Demonstrating Long-Term … - May 5, 2008 Unique Three-Year Data Demonstrating Long-Term Efficacy and Safety of Raptiva(R) in the Treatment of Psoriasis Published in the British Journal of ... Pay-Per-View - PR Newswire Europe - HighBeam Research Event Brief of Q1 2006 Serono SA Earnings Conference Call - Part 1. - Apr 20, 2006 PARTICIPANTS . Sebastian Martel, Serono SA, VP IR . Ernesto Bertarelli, Serono SA, CEO . Stuart Grant, Serono SA, CFO . Franck Latrille, Serono SA, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Press Release: 73 Per Cent of Moderate-to-Severe Psoriasis Patients … - May 23, 2005 73 Per Cent of Moderate-to-Severe Psoriasis Patients who Remained on Continuous Raptiva(r) Therapy in A 3-Year Study Achieve PASI 75. from PR Newswire ... Pay-Per-View - PR Newswire Europe - HighBeam Research Seronons 2005 Adjusted(i) EPS Increased by 34.6%. - Feb 6, 2006 GENEVA, Switzerland, February 6 /PRNewswire-FirstCall/ -- Serono (virt-x: SEO and NYSE: SRA) today reported its fourth quarter and full year results for the ... $4.95 - PR Newswire - ECNext Merck Serono and Flamel to Collaborate on an Extended Release … - Dec 20, 2007 Merck Serono and Flamel to Collaborate on an Extended Release Formulation for Therapeutic Proteins. ... find PR Newswire Europe articles. Pay-Per-View - PR Newswire Europe - HighBeam Research Assisted Reproduction; Study: Use of r-hFSH follitropin alfa in IVF... - Mar 14, 2005 The UK Gonal-f FbM PMS Group conducted "non-interventional [to assess] r-hFSH follitropin alfa FbM for the multifollicular stimulation of patients ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Merck KGaA's swings to profit of 239.1M euros as sales rise 8.3% on … - May 5, 2008 Merck KGaA's swings to profit of 239.1M euros as sales rise 8.3% on Erbitux and Rebif. Germany-based Merck KGaA's total revenues in the first quarter of ... $9.94 - Pharma Marketletter - Alacra Store … Controlled Stimulation With MENOPUR(R) Than Gonal-f(R) in Ovulation... - Jun 7, 2006 SUFFERN, NY, June 7 /PRNewswire/ -- A head-to-head study of MENOPUR(R) (menotropins for injection, USP), highly purified human menopausal gonadotropin ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Merck Serono's Cyanokit(R) Recommended for European … - Sep 24, 2007 Merck Serono's Cyanokit(R) Recommended for European Approval. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Serono Delivers Strong Second Quarter Results. - Jul 19, 2005 ROCKLAND, Massachusetts, July 19 /PRNewswire-FirstCall/ -- Serono (virt-x: SEO and NYSE: SRA), the third largest biotechnology company in the world, ... $4.95 - PR Newswire - ECNext Press Release: Merck KGaA and Idera Pharmaceuticals to Collaborate on... - Dec 19, 2007 Merck KGaA and Idera Pharmaceuticals to Collaborate on Development of TLR9 Agonists for Treatment of Cancer. from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research Serono and Priority Healthcare Corporation Form Strategic Alliance. - Jun 14, 2005 ROCKLAND, Mass., and LAKE MARY, Fla., June 14 /PRNewswire-FirstCall/ -- Serono, Inc. (virt-x SEO) and Priority Healthcare Corporation announced today the ... $4.95 - PR Newswire - ECNext Press Release: Merck Serono's Fertility Treatment Pergoveris(TM) … - Jun 29, 2007 Merck Serono's Fertility Treatment Pergoveris(TM) Approved in European Union. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Assisted Reproduction; Study: Use of r-hFSH follitropin alfa in IVF... - Mar 17, 2005 2005 MAR 17 - (NewsRx.com) -- Researchers with Serono Ltd., Feltham, UK, and the UK Gonal-f FbM PMS Group reported study results indicating that use of ... Pay-Per-View - Women's Health Weekly - Factiva, from Dow Jones Event Brief of Q2 2006 Serono SA Earnings Conference Call - Part 1. - Jul 27, 2006 PARTICIPANTS . Sebastien Marcel, Serono SA, VP IR . Ernesto Bertarelli, Serono SA, CEO . Stuart Grant, Serono SA, CFO . Jim Hoyes, Serono SA, EVP, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Merck KGaA beantragt Zulassung für Gonal-f zur Ovulationsinduktion in... - Oct 24, 2008 Darmstadt (aktiencheck.de AG) - Die Merck KGaA und ihre Konzernsparte Merck Serono haben beim japanischen Ministerium für Gesundheit, Arbeit und Soziales ... Euro am Sonntag Press Release: Merck Serono Announces Initiation of Phase II/III... - Dec 13, 2007 Merck Serono Announces Initiation of Phase II/III Clinical Trial of Atacicept in Lupus Nephritis. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Clinical Merit of Menopur in IVF - Jun 27, 2005 New data presented today at the ESHRE (European Society of Human Reproduction and Embryology) congress supports the efficacy of MENOPUR (menotrophin), ... i-newswire.com Serono 3rd-qtr sales rise but profits dip.(Serono AG)(Brief Article) - Oct 31, 2005 Europe's largest biotechnology firm, the Switzerland-based Serono Group, has reported total third-quarter 2005 revenues of $638.3 million, ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Bold bets: Serono is muscling its way into the US market with head-to... - Jan 1, 2005 From its origins as a small company making reproductive hormones to its current status as market leader in multiple sclerosis, Serono has always done things ... Free with registration - Pharmaceutical Executive - AccessMyLibrary.com Test-tube reproduction is no longer a big business, says Carey... - Nov 28, 2005 Erica Whittaker, a Merrill Lynch analyst, projects annual growth rates for sales of Gonal-F, one of the main IVF drugs, of about 5 per cent in the near ... Calcutta Telegraph Press Release: Merck Serono Launches Expansion of Flagship Biotech … - Nov 12, 2008 Merck Serono Launches Expansion of Flagship Biotech Center to Meet Growing Patient Needs. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Serono Swings to Profit Amid Strong Drug Sales - Apr 20, 2006 By STEFANIE WEITZ. GENEVA -- Serono SA -- Europe's largest biopharmaceutical company in terms of sales -- Thursday swung to a $179.9 million net profit for ... Subscription - Wall Street Journal Online - Dow Jones & Company Unterschied Puregon und Gonal F. - Künstliche Befruchtung und … - Sep 3, 2007 ...ich hätte gerne gewusst, was genau der Unterschied bei Puregon und bei Gonal F. ist. Warum geben die einen das eine und andere das andere? ... QualiMedic Fertility LifeLines(TM) Offers Single Destination for Access to... - Aug 10, 2005 ROCKLAND, Mass., Aug. 10 /PRNewswire/ -- Fertility LifeLines, a free and confidential educational service from Serono, Inc., has enhanced its services to ... $4.95 - PR Newswire - ECNext Brooke Shields Lends Her Support to Encourage Women to Take Action … - Nov 3, 2005 NEW YORK, Nov. 3 /PRNewswire/ -- Today Brooke Shields teams up with Fertility LifeLines(TM) to announce a national infertility awareness campaign ... $4.95 - PR Newswire - ECNext Press Release: /KILLKILLKILL -- Merck Serono/. - PR Newswire Europe |... - May 31, 2008 .../KILLKILLKILL -- Merck Serono/. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Serono Reports Strong Full Year 2004 Results; Total Revenues Grew … - Feb 1, 2005 Serono (virt-x: SEO and NYSE: SRA), the world's third largest biotechnology company, today reported its fourth quarter and full year results for the period ... $4.95 - PR Newswire - ECNext Serono's Net Profit Rises 72% on Lower Costs - Feb 7, 2006 By STEFANIE WEITZ. ZURICH -- Serono SA Monday reported a 72% rise in fourth-quarter net profit, helped by a decline in expenses, and said it was still ... Subscription - Wall Street Journal Online - Dow Jones & Company New Study Adds Weight to Clinical Merit of MENOPUR in IVF - Jun 20, 2005 New data presented today at the ESHRE (European Society of Human Reproduction and Embryology) congress supports the efficacy of MENOPUR (menotrophin), ... Pay-Per-View - ots - Originaltextservice Switzerland - Factiva, from Dow Jones Serono Delivers Strong First Quarter 2006 With Revenue Growth of 16.4... - Apr 20, 2006 GENEVA, Switzerland, April 20 /PRNewswire-FirstCall/ -- Serono (virt-x: SEO and NYSE: SRA), today reported its first quarter results for the period ended ... $4.95 - PR Newswire - ECNext Serono SA - Jun 19, 2006 GICS Sector Health Care. Sub-Industry Biotechnology. Comment One of the world's largest biotechnology companies, Switzerland's Serono ... $35.00 - Stock Reports - Standard & Poor's Press Release: Serono and Syntonix to Pursue the Development of a … - Sep 18, 2006 Serono and Syntonix to Pursue the Development of a Long-Acting, Inhaleable FSH Therapy to Treat Infertility. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research clomiphene | Definition of clomiphene | HighBeam.com: Online Dictionar... - Jul 12, 2006 Find out what clomiphene means: The Oxford American College Dictionary has the definition of clomiphene. Research related newspaper, magazine, ... Pay-Per-View - Oxford American College Dictionary - HighBeam Research Ferring Pharmaceuticals Announces Launch of New Treatment for … - Apr 11, 2005 SUFFERN, NY, April 11 /PRNewswire/ -- Ferring Pharmaceuticals announced today the launch of MENOPUR(R) (menotropins for injection, USP), a purified human ... $4.95 - PR Newswire - ECNext Press Release: Merck Serono's Kuvan(R) Receives Marketing … - Dec 9, 2008 Merck Serono's Kuvan(R) Receives Marketing Authorization in Europe. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Merck Serono and Bionomics Announce Multiple … - Jun 18, 2008 Merck Serono and Bionomics Announce Multiple Sclerosis Development and Licensing Agreement. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Nizak nivo estradiola tokom IVF - Nov 2, 2007 Ne koristim vise Lupron, već Gonal F ujutru i uvece Gonal F i Menopur. ... Tako su dr odlucili da prekinem sa Suprefaktom, i povecali su Gonal F za trećinu, ... Serbian Cafe James Greenwood Assumes BIO Presidency as Industry Has Banner … - Jan 5, 2005 WASHINGTON, Jan. 5 /PRNewswire/ -- Former Pennsylvania congressman James Greenwood has assumed the post of president of the Biotechnology Industry ... $4.95 - PR Newswire - ECNext Press Release: Glucophage(R) Powder for Oral Solution in Sachet … - Sep 10, 2008 Glucophage(R) Powder for Oral Solution in Sachet Receives Positive Opinion for Approval in Europe. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Merck Serono and Ablynx Enter Into an Agreement to Co-... - Sep 4, 2008 Merck Serono and Ablynx Enter Into an Agreement to Co-Discover and Co-Develop Nanobodies(R). from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Merck Serono Named as a Top Employer by Science … - Oct 10, 2008 Merck Serono Named as a Top Employer by Science Magazine. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Merck Serono Announces Initiation of Second Phase... - Jun 5, 2008 Merck Serono Announces Initiation of Second Phase II/III Clinical Study of Atacicept in Lupus.(Clinical report) from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research Viestin aihe: Gonal-F huoneenlämmössä - Aug 18, 2008 ST:lle: Muistelen että silloin kun käytin Gonal-F:ää, niin sen voi pitää huoneenlämmössä (20 astetta) 28 päivää. Kysy vaikka apteekista varmuuden vuoksi!! ... Verkkoklinikka Infertility in Women Medications - Infertility in Women Health... - Oct 29, 2007 Fertility drugs are often used alone as initial treatment to induce ovulation. If they fail as sole therapy, they may be used with assisted reproductive ... New York Times Gonal F, Predalon, Utrogest ?? - Künstliche Befruchtung und … - Nov 23, 2006 Ich war lange nicht mehr hier. Brauchte nach meiner Fehlgeburt im letzten Jahr eine Auszeit. Gestern war ich in Dortmund im KiWu-Zentrum. ... QualiMedic Double Dose of Disappointment for Serono - Apr 6, 2005 The next biggest product is the fertility drug Gonal-f, which produced $573 million in revenue. Serono said it decided to stop work on the psoriasis ... TheStreet.com - TheStreet.com (subscription) New drugs hold the hope of a revolution in AIDS care | Article from … - Feb 16, 2007 New drugs hold the hope of a revolution in AIDS care ... find International Herald Tribune articles. John Lauerman and Allan Dodds Frank International ... Pay-Per-View - International Herald Tribune - HighBeam Research Non più farmaci ad estrazione umana - May 17, 2005 La penna della fertilità , le penna che serve per fare i bambini. L'hanno chiamata in tanti modi. Si tratta di una penna preriempita con un dispositivo di ... TGCOM Cancer 'Vaccine' Is Set Back as Treatment Fails in Trial - Apr 7, 2005 By ANDREW POLLACK and TOM WRIGHT. LOS ANGELES, April 6 - A cancer treatment that has been under development for more than 40 years failed in the first ... New York Times Serono Q3 net beats expectations but revenues weak UPDATE - Oct 25, 2005 ZURICH (AFX) - Serono SA third quarter net income beat market consensus but product sales and total revenues at the Swiss biotech company were weaker than ... Forbes Swiss shares close higher tracking Wall Street, pharmaceuticals down ... - Jul 27, 2006 ZURICH (AFX) - Swiss shares closed higher tracking an early Wall Street rise, though gains were capped by losses in pharmaceuticals, dealers said. ... Forbes Swiss shares move higher in quiet trade tracking Wall St; luxury... - Oct 25, 2005 ZURICH (AFX) - Share prices were higher in quiet trade tracking overnight gains on Wall Street, with the luxury goods sector in demand on the back of strong ... Forbes On the Move: Serono, Royal Dutch Shell, DaimlerChrysler - Jan 24, 2006 ARCELOR was up €0.70 to €21.61 on news that the steel group signed a deal to buy Dofasco, Canada's biggest steel producer. Arcelor had received notification ... BusinessWeek Swiss shares higher midmorning, tracking other mkts, led by banks; … - Feb 6, 2006 ZURICH (AFX) - Share prices were higher midmorning, tracking other European markets, led by banking stocks after France's BNP Paribas offered 9 bln eur for ... Forbes Serono's Siren Song - Jan 13, 2006 On Rebif's horizon, however, are some potential drawbacks, including the possible resurrection of Tysabri from Biogen Idec (BIIB - commentary - Cramer's ... TheStreet.com - TheStreet.com (subscription) Female infertility - Jan 11, 2008 Female infertility, male infertility or a combination of the two affects millions of couples in the United States. An estimated 10 percent to 15 percent of ... CNN International Lourde perte pour Serono en 2005 - Feb 6, 2006 Serono a essuyé une perte nette de 106,1 millions de dollars (137,2 millions de francs) l'an dernier, suite à une grosse amende payée aux Etats-Unis. ... TSR.ch Rivals Glaxo, Novartis reported close to making bids for Serono - Jan 12, 2006 By Carey Sargent and Julia Werdigier, Bloomberg News | January 12, 2006. GlaxoSmithKline PLC and Novartis AG are considering bids for Serono SA, ... Boston Globe Bertarelli close to the wind - Apr 12, 2006 The billionaire Bertarelli family has ended a five-month search for a buyer for Europe's largest biotechnology company because the offers were too low. ... New Zealand Herald Un stylo injecteur pour les hormones de fertilité - Nov 9, 2005 En modernisant l'administration de son produit phare, Serono a pu relancer sa croissance en améliorant le confort des patientes. ... €3.00 - Les Echos Novartis and Glaxo consider biotech bidMOVERSMARKETPLACE by … - Jan 12, 2006 Novartis and Glaxo consider biotech bidMOVERSMARKETPLACE by Bloomberg ... find International Herald Tribune articles. International Herald Tribune ... Pay-Per-View - International Herald Tribune - HighBeam Research Article: GERMAN CARMAKERS LIFT SALES HOT STOCKS - International … - May 7, 2008 GERMAN CARMAKERS LIFT SALES HOT STOCKS ... find International Herald Tribune articles. Reuters International Herald Tribune 05-07-2008 GERMAN CARMAKERS LIFT ... Pay-Per-View - International Herald Tribune - HighBeam Research Swiss firm halts plans for 2 drugsFailed late-stage tests hurt Serono'... - Apr 7, 2005 Swiss firm halts plans for 2 drugsFailed late-stage tests hurt Serono's outlook ... find International Herald Tribune articles. Pay-Per-View - International Herald Tribune - HighBeam Research Drug maker Serono reports profit dropMOVERSMARKETPLACE by … - Feb 7, 2006 Shares of Serono, which sells the multiple sclerosis therapy Rebif and fertility drug Gonal-f, fell when the company said it hired Goldman Sachs to explore ... Pay-Per-View - International Herald Tribune - HighBeam Research Serono ends bid to attract a buyerMARKETPLACE by Bloomberg | Article ... - Apr 11, 2006 Serono ends bid to attract a buyerMARKETPLACE by Bloomberg ... find International Herald Tribune articles. Carey Sargent and Chantal Britt International ... Pay-Per-View - International Herald Tribune - HighBeam Research Moniteur Belge - Belgisch Staatsblad - Sep 20, 2006 14 SEPTEMBRE 2006. - Arrêté ministériel modifiant la liste jointe à l'arrêté royal du 21 décembre 2001 fixant les procédures, délais et conditions en ... Belgisch Staatsblad Merck KGaA Cuts Liquid-Crystals Goal on Currency Woes - Oct 27, 2008 By Naomi Kresge. Oct. 27 (Bloomberg) -- Merck KGaA, the world's biggest maker of liquid crystals for flat-panel televisions, lowered margin targets for the ... Bloomberg Swiss star finds it tough at the top - Dec 1, 2005 Serono is calling in outside advice. Colin Macilwain investigates the future of Europe's leading biotech firm. Large-scale success has eluded most European ... Nature.com Brand Names/Synonyms: Gonal-F is also known by the following brand names and/or synonymsFollitropin beta chain precursor;Follicle-stimulating hormone beta subunit;FSH-beta;FSH-B; Gonal-F Drug Category: Gonal-F is categorized under the following by the FDA: Fertility Agents; gonadotropins (68:18.00) Dosage Forms: SOLUTION Absorption: Not Available Interactions: Not Available Chemical IUPAC Name: Human follicle stimulating hormone |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |